Alex Howarth
President chez JBR Pharma, Inc.
Fortune : 4 M $ au 30/04/2024
Postes actifs de Alex Howarth
Sociétés | Poste | Début | Fin |
---|---|---|---|
JBR Pharma, Inc.
JBR Pharma, Inc. Pharmaceuticals: MajorHealth Technology JBR Pharma, Inc. operates as a virtual pharmaceutical company. The company is headquartered in Plymouth Meeting, PA. | President | - | - |
Historique de carrière de Alex Howarth
Anciens postes connus de Alex Howarth
Sociétés | Poste | Début | Fin |
---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Directeur Financier/CFO | 17/05/2021 | 11/03/2024 |
Investor Relations Contact | 17/05/2021 | 29/01/2024 | |
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | Directeur Financier/CFO | 06/10/2015 | 01/01/2019 |
President | 01/01/2019 | 01/11/2019 | |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Directeur Financier/CFO | 19/08/2009 | 01/09/2015 |
VITAE PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2004 | 01/01/2007 |
GSK PLC | Directeur/Membre du Conseil | 01/01/1995 | 01/01/2000 |
Corporate Officer/Principal | 01/01/2000 | 01/01/2005 | |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1991 | 01/01/1995 |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | 01/01/1989 | 01/01/1990 |
AKCEA THERAPEUTICS, INC. | Directeur des opérations | 02/12/2019 | - |
░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Alex Howarth
University of Bath | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Royaume-Uni | 4 |
Opérationnelle
Corporate Officer/Principal | 5 |
Director of Finance/CFO | 3 |
President | 2 |
Sectorielle
Health Technology | 10 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
GSK PLC | Health Technology |
MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 7 |
---|---|
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | Health Technology |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
JBR Pharma, Inc.
JBR Pharma, Inc. Pharmaceuticals: MajorHealth Technology JBR Pharma, Inc. operates as a virtual pharmaceutical company. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
- Bourse
- Insiders
- Alex Howarth
- Expérience